Public health insurance and pharmaceutical innovation: Evidence from China
Developing countries are characterized by low levels of pharmaceutical innovation. A likely reason is their small market size, which is not because of the population size but because of low levels of income and lack of health insurance coverage. This study exploits a natural experiment from the impl...
Saved in:
Main Authors: | ZHANG, Xuan, NIE, Huihua |
---|---|
Format: | text |
Language: | English |
Published: |
Institutional Knowledge at Singapore Management University
2021
|
Subjects: | |
Online Access: | https://ink.library.smu.edu.sg/soe_research/2407 https://ink.library.smu.edu.sg/context/soe_research/article/3406/viewcontent/NCMS_innovation_JDE_RR2.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Singapore Management University |
Language: | English |
Similar Items
-
The 1st Pharmaceutical Sciences Asia Conference 2019 Theme : Pharmaceutical Sciences toward Health Innovation in the Disruptive Era
Published: (2020) -
Transnational Intellectual Property Strategies and Firms’ Knowledge Adoption: Evidence from China-U.S. Patent Dyads
by: HUANG, Kenneth Guang-Lih, et al.
Published: (2012) -
Transnational Intellectual Property Strategies and Firms’ Knowledge Adoption: Evidence from China-U.S. Patent Dyads
by: HUANG, Kenneth Guang-Lih, et al.
Published: (2012) -
The Effect of Hardship on Innovation: A Study on China's Great Famine.
by: Lim Jin Ming
Published: (2018) -
Employment Nondiscrimination Acts and Corporate Innovation
by: Gao, Huasheng, et al.
Published: (2017)